Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Income Statement [Abstract]
Revenues		$ 1,552		$ 7,437
Operating expenses:
Research and development	14	2,834	33	6,346
General and administrative	1,534	2,001	3,362	3,627
Loss on MannKind Transaction		2,618		2,618
Total operating expenses	1,548	7,453	3,395	12,591
Loss from operations	(1,548)	(5,901)	(3,395)	(5,154)
Other income (expense):
Interest income	41	133	94	293
Fair value adjustment of warrants	1		67
Other expense, net	(43)	(43)	(123)	(125)
Total other income (expense), net	(1)	90	38	168
Net loss	$ (1,549)	$ (5,811)	$ (3,357)	$ (4,986)
Net loss per share attributable to common stockholders basic	$ (0.42)	$ (1.59)	$ (0.92)	$ (1.37)
Net loss per share attributable to common stockholders diluted	$ (0.42)	$ (1.59)	$ (0.92)	$ (1.37)
Weighted average common shares outstanding basic	3,652,285	3,652,285	3,652,285	3,652,285
Weighted average common shares outstanding diluted	3,652,285	3,652,285	3,652,285	3,652,285